To better understand the role of SF3B1 mutations in CLL, Yin et al. developed a conditional knock-in mouse model with a B cell-specific expression of the Sf3b1-K700E mutation, enabling to explore its impact on the disease’s pathogenesis. The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.